Why Older Adults Get Less Protection From Flu and Shingles Vaccines
A completed Phase 2 trial investigates the immune mechanisms behind age-related vaccine failure in older adults.
59 articles in this topic
A completed Phase 2 trial investigates the immune mechanisms behind age-related vaccine failure in older adults.
A Phase 2 trial evaluates MBA-P01, a novel botulinum toxin A, for safety and optimal dosing in treating frown lines.
A Phase 1/2 trial tests four rounds of intrathecal MSC injections in ALS patients, targeting both safety and disease progression.
A terminated multicenter RCT examined whether mechanical cough assistance plus NIV could cut re-intubation rates in ICU patients with weak cough.
A Phase 2 pilot trial investigates whether the natural senolytic compound fisetin can reduce dysfunction and complications in COVID-19 patients.
A completed RCT from the University of Copenhagen tests whether aerobic exercise, time-restricted feeding, or NR supplementation best improves biological aging markers in healthy older adults.
28-day trial of 108 participants found specific breathing techniques outperformed mindfulness meditation for stress reduction and wellbeing.
Small trial tests autologous bronchial stem cells to repair damaged lung tissue in chronic obstructive pulmonary disease patients.
Adipose-derived stem cells combined with platelet-rich plasma evaluated for treating moderate to severe knee osteoarthritis over 2 years.
Small trial tests blood-derived therapy for persistent post-surgical ear infections that resist standard treatments.
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Researchers compared stem cells from arthritis patients versus healthy donors to assess regenerative therapy potential.